Cue Biopharma

CUENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$113.913 M

$27.12 +0.41%

Close of 7 Aug 2026

Revenue

$27.5M

#2918 by revenue

Earnings

-$26.6M

Loss-making

Shares outstanding

97,660,791

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#300Cumberland PharmaceuticalsCPIX$116.9M
#301Anixa BiosciencesANIX$116.4M
#302Cue BiopharmaCUE$113.9M
#303Coya TherapeuticsCOYA$112.8M
#304Polaryx TherapeuticsPLYX$112.7M

Where these numbers come from

Share counts and financials for Cue Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.